Search - tctmd.com

Displaying 61 - 80 of 174

Sort: Relevancy | Date

News Conference News LINC 2023

What Works, What’s Noise? Novel Approaches Offer Hope in CLTI

L.A. McKeown

June 07, 2023

News Features

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

L.A. McKeown

May 12, 2023

News Daily News

Think Differently: Diabetes, CVD Risks in Asian Americans Not Uniform, AHA Says

Caitlin E. Cox

May 09, 2023

News Daily News

To Improve CV Care in US South Asians, Understand Unique ASCVD Risks: ACC

Yael L. Maxwell

April 12, 2023

News Daily News

Regaining Weight Won’t Erode CV Risk Factor Benefits Short Term

L.A. McKeown

March 31, 2023

News Conference News CRT 2023

In CABG/PCI Decisions for Left Main Disease, Diabetes ‘Still Matters’

Yael L. Maxwell

March 01, 2023

News Daily News

Food Insecurity May Drive Heart Failure, CAD Risks in Black Individuals

L.A. McKeown

February 06, 2023

News Daily News

Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees

Michael O'Riordan

January 05, 2023

News Daily News

Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS

Michael O'Riordan

December 30, 2022

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

News Conference News AHA 2022

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Michael O'Riordan

November 06, 2022

News Conference News AHA 2022

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Michael O'Riordan

November 05, 2022

News Daily News

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

L.A. McKeown

October 05, 2022

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

Shelley Wood

August 22, 2022

News Daily News

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

Shelley Wood

July 25, 2022

News Conference News EAS 2022

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Michael O'Riordan

May 24, 2022

News Conference News ESC Heart Failure 2022

Dapagliflozin Boosts Health Status Across LVEF Range

Shelley Wood

May 23, 2022

News Daily News

Good News and Bad for High-Intensity Statin Use in ASCVD

Michael O'Riordan

May 05, 2022

News Daily News

As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control

Caitlin E. Cox

January 10, 2022

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Shelley Wood

November 08, 2021

Advertisement

What Works, What’s Noise? Novel Approaches Offer Hope in CLTI

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

Think Differently: Diabetes, CVD Risks in Asian Americans Not Uniform, AHA Says

To Improve CV Care in US South Asians, Understand Unique ASCVD Risks: ACC

Regaining Weight Won’t Erode CV Risk Factor Benefits Short Term

In CABG/PCI Decisions for Left Main Disease, Diabetes ‘Still Matters’

Food Insecurity May Drive Heart Failure, CAD Risks in Black Individuals

Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees

Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

What’s Going to Be Hot at ESC 2022?

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Dapagliflozin Boosts Health Status Across LVEF Range

Good News and Bad for High-Intensity Statin Use in ASCVD

As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content